TR200200467T2 - Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi. - Google Patents

Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi.

Info

Publication number
TR200200467T2
TR200200467T2 TR2002/00467T TR200200467T TR200200467T2 TR 200200467 T2 TR200200467 T2 TR 200200467T2 TR 2002/00467 T TR2002/00467 T TR 2002/00467T TR 200200467 T TR200200467 T TR 200200467T TR 200200467 T2 TR200200467 T2 TR 200200467T2
Authority
TR
Turkey
Prior art keywords
delivery system
drug delivery
oral drug
stomach
hydrodynamic balancing
Prior art date
Application number
TR2002/00467T
Other languages
English (en)
Inventor
Talwar Naresh
N. Staniforth John
J. Tobyn Michael
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of TR200200467T2 publication Critical patent/TR200200467T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut bulus, en az bir ilaç maddesi, seker(ler), gaz olusturma bilesenleri ve istege bagli olarak farmasötik açidan kabul edilebilir yardimci bilesenlerden olusan oldukça gözenekli bir matris içeren, midede tutulan oral ilaç verme sistemi ile ilgilidir. Topaklar (çok partikülatli veya tek üniteli dozaj formu), taneler, granüller veya kapsüller formundaki farmasötik kompozisyon midede tutulurken ilaç(lar) uzun bir süre zarfinda ince bagirsagin üst kisimlarinda ve mide seviyelerinde seçici olarak birakilir.
TR2002/00467T 1999-08-04 2000-08-01 Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi. TR200200467T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system

Publications (1)

Publication Number Publication Date
TR200200467T2 true TR200200467T2 (tr) 2002-08-21

Family

ID=11004886

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00467T TR200200467T2 (tr) 1999-08-04 2000-08-01 Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi.

Country Status (21)

Country Link
EP (1) EP1206249A4 (tr)
JP (1) JP2003506400A (tr)
CN (1) CN1376059A (tr)
AP (1) AP2002002410A0 (tr)
AU (2) AU5060499A (tr)
BR (1) BR0012981A (tr)
CA (1) CA2378468A1 (tr)
CZ (1) CZ2002415A3 (tr)
EA (1) EA200200126A1 (tr)
HK (1) HK1047226A1 (tr)
HR (1) HRP20020108A2 (tr)
HU (1) HUP0202497A3 (tr)
IL (1) IL147966A0 (tr)
MX (1) MXPA02001272A (tr)
NZ (1) NZ516959A (tr)
OA (1) OA12003A (tr)
PL (1) PL353321A1 (tr)
SK (1) SK1832002A3 (tr)
TR (1) TR200200467T2 (tr)
WO (2) WO2001010405A1 (tr)
ZA (1) ZA200200926B (tr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (ko) * 2001-04-02 2004-11-17 삼아약품 주식회사 속용정 및 그의 제조방법
RU2325152C2 (ru) 2001-07-04 2008-05-27 Сан Фармасьютикл Индастриз Лимитид Удерживаемая в желудке система регулируемой доставки лекарственного средства
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2005020879A2 (en) * 2003-08-27 2005-03-10 Vecta Ltd. Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
CA2569919A1 (en) * 2004-06-28 2006-01-05 Solvay Pharmaceuticals B.V. Oral sustained release formulation of tedisamil with gastric retention properties
UA93608C2 (ru) 2004-08-13 2011-02-25 Берингер Ингельхайм Интернациональ Гмбх композициЯ таблетки пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, СПОСОБ EE ИЗГОТОВЛЕНИЯ И EE ПРИМЕНЕНИЕ
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
BRPI0620268B8 (pt) 2005-12-22 2021-05-25 Oakwood Laboratories LLC composição eficaz como sistema de fornecimento para liberação controlada, seu uso, seu método de fabricação, e método para proteger um agente biologicamente ativo
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
ATE476176T1 (de) * 2007-03-02 2010-08-15 Farnam Co Inc Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung
CN102202656A (zh) 2008-08-15 2011-09-28 蒂宝制药公司 治疗和预防cns障碍的胃滞留药用组合物
JP2012500230A (ja) 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
WO2010041279A2 (en) * 2008-10-08 2010-04-15 V.B. Medicare Pvt. Ltd. Sustained release drug delivery system
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
JP2013103879A (ja) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd ハードカプセル
KR102241487B1 (ko) 2013-02-20 2021-04-16 주식회사 종근당 제어방출 펠릿으로 된 약제학적 조성물
JP6466399B2 (ja) * 2013-03-15 2019-02-06 アプレシア・ファーマスーティカルズ・カンパニー トピラマートの急速分散性の剤形
CN103462917A (zh) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 一种用于抗病毒的阿昔洛韦片剂及其制备方法
EP3468382A4 (en) * 2016-06-14 2020-01-22 Prevtec Microbia Inc ANIMAL FEED PELLETS WITH FEED ADDITIVE, METHOD FOR THE PRODUCTION AND USE THEREOF
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10918597B2 (en) 2017-06-16 2021-02-16 Kashiv Specialty Pharmaceuticals, Llc Gastroretentive dosage forms for sustained drug delivery
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
CN107375287B (zh) * 2017-08-22 2019-11-29 安徽省肿瘤医院 一种硫酸阿托品在制备治疗原发性肝癌药物中的用途
CN107441115A (zh) * 2017-08-22 2017-12-08 安徽省肿瘤医院 一种维拉帕米联合碳酸氢钠在制备原发性肝癌治疗药物中的用途
CN107349195A (zh) * 2017-08-22 2017-11-17 安徽省肿瘤医院 一种维拉帕米在制备治疗转移性肝癌药物中的用途
EP3824881B1 (en) 2018-06-18 2022-02-16 Amneal Complex Products Research LLC Extended release compositions comprising pyridostigmine
EP3970701B1 (en) 2018-06-27 2025-05-07 Amneal Complex Products Research LLC Self-regulating osmotic gastroretentive drug delivery systems
US11389398B2 (en) 2019-05-14 2022-07-19 Clexio Biosciences Ltd. Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (tr) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
EP0497977B1 (en) * 1989-10-26 1995-03-15 Nippon Shinyaku Company, Limited Gastric preparation
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua

Also Published As

Publication number Publication date
AU6309900A (en) 2001-03-05
OA12003A (en) 2006-04-18
WO2001010405A1 (en) 2001-02-15
HUP0202497A2 (hu) 2002-11-28
HUP0202497A3 (en) 2004-05-28
CN1376059A (zh) 2002-10-23
EP1206249A4 (en) 2004-12-22
AP2002002410A0 (en) 2002-03-31
PL353321A1 (en) 2003-11-17
CA2378468A1 (en) 2001-02-15
IL147966A0 (en) 2002-09-12
HK1047226A1 (zh) 2003-02-14
ZA200200926B (en) 2002-11-27
EA200200126A1 (ru) 2002-10-31
SK1832002A3 (en) 2002-08-06
MXPA02001272A (es) 2002-07-22
CZ2002415A3 (cs) 2002-08-14
WO2001010419A1 (en) 2001-02-15
HRP20020108A2 (en) 2003-12-31
BR0012981A (pt) 2002-06-18
AU774957B2 (en) 2004-07-15
NZ516959A (en) 2003-10-31
JP2003506400A (ja) 2003-02-18
EP1206249A1 (en) 2002-05-22
AU5060499A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
TR200200467T2 (tr) Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi.
IL150568A0 (en) A controlled release oral drug dosage form
PT1117386E (pt) Administracao enterica e colonica utilizando capsulas de hpmc
ZA912069B (en) Dosage form for delivering drug to the intestine
ES2284643T3 (es) Composicion de revestimiento enmascarante del sabor.
UA41995C2 (uk) Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти )
DK0939626T3 (da) Galenisk form til forlænget frigivelse af milnacipran
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
MY102459A (en) Oral sustained release pharmaceutical preparation.
KR850700212A (ko) 서방성 약제학적 캼셀제
CA2112679A1 (en) Dosage form for delivering drug in short-time period
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
NO974404L (no) Insufflasjonsbærer for medikamenter med kontrollert frigivelse
ES2035821T3 (es) Sistema de administracion enterica dirigida.
HUP0000943A2 (hu) Expandálható gasztro-retentív terápiás rendszer szabályozott hatóanyag felszabadítással a gyomor-béltraktusban
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
DK0932388T5 (da) Doseringsform og fremgangsmåde til indgivelse af lægemidler
DE59707812D1 (de) Opioidantagonisthaltige galenische formulierung
EP1365749A4 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
TR199902175T2 (tr) Parasetamol içeren yutma tableti.
KR900015724A (ko) 메베버린 용량 형태
BR0212155A (pt) Composição farmacêutica
MXPA03011317A (es) Comprimido masticable que comprende paracetamol.
HUP0104476A2 (hu) Hidroxi-propil-mutil-cellulóz kapszulákban formázott gyógyszerkészítmények
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény